Fatma Acil
Diyarbakır, Outside of the US, 21070, Turkey (Türkiye)
NCT Number: NCT07422649
This retrospective cohort study examined clinical outcomes in patients who underwent mechanical thrombectomy for acute ischemic stroke under general anesthesia or sedoanalgesia. Patient data from 2014 to 2018 were obtained from hospital medical records. Mortality and neurological outcomes were compared between anesthesia groups.
Looking for future studies?
Notify Me18 year–100 year
All sexes
Observational
Diyarbakır, Outside of the US, 21070, Turkey (Türkiye)
This retrospective observational cohort study was conducted at the University of Health Sciences Bakirkoy Dr. Sadi Konuk Training and Research Hospital. Medical records of patients who underwent mechanical thrombectomy for acute ischemic stroke between 2014 and 2018 were reviewed. Patients who received mechanical thrombectomy within 6 hours of symptom onset and achieved a Thrombolysis in Cerebral Infarction (TICI) reperfusion grade of 2a, 2b, or 3 were included. Patients with TICI grades of 0 or 1, those younger than 18 years, patients with an APACHE II score ≥25, a Glasgow Coma Scale score <10, those requiring endotracheal intubation before the procedure, or patients discharged from the procedure intubated to the intensive care unit were excluded.
Based on anesthesia records, patients were classified into two cohorts: those who underwent the procedure under general anesthesia and those managed with sedoanalgesia. No assignment to anesthesia technique was performed as part of the study, and anesthesia management was determined according to routine clinical practice. Demographic characteristics, medical history, radiological findings, procedural details, and perioperative variables were extracted from hospital records. Neurological status was assessed using the National Institutes of Health Stroke Scale (NIHSS) at 4 and 24 hours after the procedure, and functional outcome was evaluated using the modified Rankin Scale during hospitalization and at 3 months after thrombectomy. Intraoperative bispectral index (BIS) values and cerebral oxygenation measured by near-infrared spectroscopy (NIRS) were recorded when available. Safety outcomes including peri-procedural hemodynamic instability, vasopressor or antihypertensive use, need for pacing, and intensive care unit (ICU) length of stay will be evaluated.
Neurological outcomes will be assessed longitudinally using NIHSS at baseline, 4 hours, 24 hours, and modified Rankin Scale (mRS/TICI) immediately after the procedure and at 3 months.
The primary outcome of the study was all-cause mortality. Secondary outcomes included neurological and functional outcomes, perioperative variables, intensive care unit length of stay, and procedure-related complications. Comparisons between anesthesia cohorts were performed using routinely collected clinical data. Postoperative delirium occurring during the first 7 days after the procedure was evaluated as a secondary safety outcome when documented in the medical records
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Patients who underwent mechanical thrombectomy under general anesthesia, based on anesthesia records.
Patients who underwent mechanical thrombectomy under sedoanalgesia, based on anesthesia records.
Time frame: During index hospitalization and at 3 months post-procedure
Comparison of all-cause mortality between patients undergoing mechanical thrombectomy under general anesthesia and sedoanalgesia.
Time frame: Baseline, 4 hours, 24 hours post-procedure
The National Institutes of Health Stroke Scale (NIHSS) is used to quantify stroke severity (score range 0-42; higher scores indicate more severe stroke)
Time frame: Immediately after completion of the angiographic procedure and at 3 months after the initial thrombectomy
The modified Rankin Scale (mRS) is a global functional outcome measure used after stroke to categorize the level of functional independence.
Time frame: Immediately after completion of the angiographic procedure and at 3 months after the initial thrombectomy.
The Thrombolysis in Cerebral Infarction (TICI) grading system is used after endovascular revascularization to describe angiographic reperfusion (e.g., 0-3; higher grades indicate better reperfusion)
Time frame: During index hospitalization and at 3 months post-procedure
Regional cerebral oxygen saturation was monitored using near-infrared spectroscopy (NIRS) during the procedure and throughout the early postoperative period.
Time frame: During the procedure
Depth of anesthesia was monitored using bispectral index (BIS) values recorded during the procedure.
Time frame: During the procedure
Total duration of the mechanical thrombectomy procedure.
Time frame: At the time of the procedure
Elapsed time between symptom onset and initiation of mechanical thrombectomy.
Time frame: Through study completion, an average of 3 months
Duration of stay in the intensive care unit following the procedure
Time frame: From procedure until 3 months post-procedure
Systolic and diastolic blood pressure values recorded during the perioperative period
Time frame: During hospitalization
Occurrence of neurological or procedure-related complications during hospitalization
Time frame: Within 30 days after procedure
Incidence of postoperative delirium during the first 3 postoperative months
Time frame: Within 30 days after procedure
Incidence of postoperative delirium during the first 3 postoperative months
Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital
Other
Comparison of General Anesthesia and Sedoanalgesia on Mortality and Neurological Outcomes in Patients Undergoing Mechanical Thrombectomy for Acute Ischemic Stroke
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05953480
Acute Ischemic Stroke, Brain Diseases
Tucson, Arizona, United States
View Trial DetailsNCT05965687
Acute Ischemic Stroke, Brain Diseases
Beijing, China
View Trial DetailsNCT06101667
Acute Ischemic Stroke, Basilar Artery Occlusion
Beijing, Beijing Municipality, China
View Trial DetailsNCT06638151
Acute Ischemic Stroke, Brain Diseases
Edmonton, Alberta, Canada
View Trial Details